AIM To investigate the contribution of polymorphisms in the CYP1A1, CYP2E1 and EPHX1 genes on sporadic colorectal cancer(SCRC) risk. METHODS Six hundred forty-one individuals(227 patients with SCRC and 400 controls) were enrolled in the study. The variables analyzed were age, gender, tobacco and alcohol consumption, and clinical and histopathological tumor parameters. The CYP1A1 *2A, CYP1A1 *2C CYP2E1 *5B and CYP2E1 *6 polymorphisms were analyzed by polymerase chain reaction-restriction fragment length polymorphism(PCR-RFLP). The EPHX1 Tyr113 His, EPHX1 His139 Arg and CYP1A1 *2C polymorphisms were detected by real-time PCR. Chisquared test and binary logistic regression were used in the statistical analysis. Haplotype analysis was conducted using the Haploview program, version 2.05.RESULTS Age over 6 2 years was a risk factor for SCRC development(OR = 7.54, 95%CI: 4.94-11.50, P < 0.01). Male individuals were less susceptible to SCRC(OR = 0.55, 95%CI: 0.35-0.85, P < 0.01). The CYP2E1*5B polymorphism was associated with SCRC in the codominant(heterozygous genotype: OR = 2.66, 95%CI: 1.64-4.32, P < 0.01), dominant(OR = 2.82, 95%CI: 1.74-4.55, P < 0.01), overdominant(OR = 2.58, 95%CI: 1.59-4.19, P < 0.01), and log-additive models(OR = 2.84, 95%CI: 1.78-4.52, P < 0.01). The CYP2E1*6 polymorphism was associated with an increased SCRC risk in codominant(heterozygous genotype: OR = 2.81, 95%CI: 1.84-4.28, P < 0.01; homozygous polymorphic : OR = 7. 3 2, 9 5 % C I : 1.85-28.96, P < 0.01), dominant(OR = 2.97, 95%CI: 1.97-4.50, P < 0.01), recessive(OR = 5.26, 95%CI: 1.35-20.50, P = 0.016), overdominant(OR = 2.64, 95%CI: 1.74-4.01, P < 0.01), and log-additive models(OR = 2.78, 95%CI: 1.91-4.06, P < 0.01). The haplotype formed by the minor alleles of the CYP2E1*5B(C) and CYP2E1*6(A) polymorphisms was associated with SCRC(P = 0.002). However, the CYP1A1 *2A, CYP1A1 *2C, EPHX1 Tyr113 His and EPHX1 His139 Arg polymorphisms were not associated with SCRC.CONCLUSION In conclusion, the results demonstrated that CYP2E1*5B and CYP2E1*6 minor alleles play a role in the development of SCRC. AIM To investigate the contribution of polymorphisms in the CYP1A1, CYP2E1 and EPHX1 genes on sporadic colorectal cancer (SCRC) risk. METHODS Six hundred forty-one individuals (227 patients with SCRC and 400 controls) were enrolled in the study. The population analyzed were age, gender, tobacco and alcohol consumption, and clinical and histopathological tumor parameters. The CYP1A1 * 2A, CYP1A1 * 2C CYP2E1 * 5B and CYP2E1 * 6 polymorphisms were analyzed by polymerase chain reaction- restriction fragment length polymorphism (PCR-RFLP) EPHX1 Tyr113 His, EPHX1 His139 Arg and CYP1A1 * 2C polymorphisms were detected by real-time PCR. Chisquared test and binary logistic regression were used in the statistical analysis. Haplotype analysis was conducted using the Haploview program, version 2.05.RESULTS Age over 6 2 years were a risk factor for SCRC development (OR = 0.55, 95% CI: 0.35-0.85, P <0.01) The CYP2E1 * 5B (OR = 2.82, 95% CI: 1.74-4.55, P <0.01), overdominant (OR = 2.66, 95% CI: 1.64-4.32, OR = 2.58, 95% CI: 1.59-4.19, P <0.01), and log-additive models (OR = 2.84, 95% CI: 1.78-4.52, P <0.01). The CYP2E1 * 6 polymorphism was associated with an increased SCRC risk in codominant (OR = 2.81, 95% CI: 1.84-4.28, P <0.01; homozygous polymorphic: OR = 7.322, 95% CI: 1.85-28.96, P <0.01) (OR = 2.97, 95% CI: 1.97-4.50, P <0.01), recessive (OR = 5.26, 95% CI: 1.35-20.50, P = 0.016), overdominant The haplotype formed by the minor alleles of the CYP2E1 * 5B (C) and CYP2E1 * 6 (A), and the log-additive models (OR = 2.78, 95% CI: 1.91-4.06, P <0.01) The CYP1A1 * 2A, CYP1A1 * 2C, EPHX1 Tyr113 His and EPHX1 His139 Arg polymorphisms were not associated with SCRC.CONCLUSION In conclusion, the polymorphisms were associated with SCRC (P = 0.002)results demonstrated that CYP2E1 * 5B and CYP2E1 * 6 minor alleles play a role in the development of SCRC.